Category: CovidienSyndicate content

The silver lining for healthcare in U.S. inversion rules

November 6, 2014 by MassDevice

Instead of quashing mergers and acquisitions altogether, the U.S. Treasury Dept.'s proposal on tax inversions may pull dealmaking onshore.

Healthcare sector sees silver lining in U.S. tax inversion rules

(Reuters) - Investors and bankers have been lamenting the potential death of large cross-border healthcare mergers since the U.S. Treasury Dept. announced in late September that it would curtail the tax breaks from international deals designed to give U.S. companies a legal home in a low-tax country.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Atherectomy and balloon angioplasty beat angioplasty alone in Covidien trial

November 6, 2014 by Val Kennedy

Atherectomy and balloon angioplasty proves more effective than angioplasty alone in treating peripheral artery disease, according to new data from a Covidien study.

Atherectomy and balloon angioplasty beat angioplasty alone in Covidien trial

Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A

November 5, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic unveils post-merger management structure; Abbott buys into electrophysiology with $250m Topera acquisition; Zimmer reveals post-Biomet merger plans; Medtronic, Covidien merger expected to close in 2015; Covidien deals Stellarex balloon to Spectranetics for $30m

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Covidien beats with fiscal Q4, 2014 results

November 5, 2014 by Brad Perriello

Covidien's fiscal 4th-quarter and 2014 earnings top expectations on Wall Street as 4th-quarter profits soar 39%.

Covidien beats with fiscal Q4, 2014 results

Covidien (NYSE:COV) handily beat analysts' expectations for its fiscal 4th-quarter and full-year results this morning, topping earnings-per-share forecasts with Q4 profit growth of 39%.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien wins FDA nod for HawkOne atherectomy device

November 4, 2014 by Brad Perriello

Covidien says the FDA granted 510(k) clearance for its HawkOne atherectomy device.

Covidien wins FDA nod for HawkOne atherectomy device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien deals Stellarex balloon to Spectranetics for $30m

November 3, 2014 by Brad Perriello

Covidien agrees to deal its Stellarex drug-coated balloon to Spectranetics for $30 million is it looks to satisfy U.S. anti-trust regulators ahead of a $43 billion merger with Medtronic.

Covidien deals Stellarex balloon to Spectranetics for $30m

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Medtronic CEO Omar Ishrak unveils the plan for the medical device giant's management structure after it closes its mega-merger with Covidien early next year.

Medtronic unveils post-merger management structure
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp